131 related articles for article (PubMed ID: 1869297)
21. Antagonists and agonists interactions with the muscarinic receptor of the rat large airways.
Scott T; McMahon KK
J Pharmacol Exp Ther; 1988 Oct; 247(1):136-42. PubMed ID: 3171971
[TBL] [Abstract][Full Text] [Related]
22. The relative potencies of cholinomimetics and muscarinic antagonists on the rat iris in vivo: effects of pH on potency of pirenzepine and telenzepine.
Hagan JJ; van der Heijden B; Broekkamp CL
Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):476-83. PubMed ID: 3244389
[TBL] [Abstract][Full Text] [Related]
23. Subclassification of muscarinic receptors in the heart, urinary bladder and sympathetic ganglia in the pithed rat. Selectivity of some classical agonists.
van Charldorp KJ; de Jonge A; Thoolen MJ; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):301-6. PubMed ID: 4094621
[TBL] [Abstract][Full Text] [Related]
24. Effects of selective muscarinic antagonists, pirenzepine and AF-DX 116, on passive avoidance tasks in mice.
Ohnuki T; Nomura Y
Biol Pharm Bull; 1996 Jun; 19(6):814-8. PubMed ID: 8799478
[TBL] [Abstract][Full Text] [Related]
25. Deficits in avoidance responding after paradoxical sleep deprivation are not associated with altered [3H]pirenzepine binding to M1 muscarinic receptors in rat brain.
Moreira KM; Hipólide DC; Nobrega JN; Bueno OF; Tufik S; Oliveira MG
Brain Res; 2003 Jul; 977(1):31-7. PubMed ID: 12788510
[TBL] [Abstract][Full Text] [Related]
26. Effects of muscarinic receptor agonists and antagonists on dopamine-mediated behavioural paradigms.
Bhattacharya SK; Sen AP
J Neural Transm Gen Sect; 1991; 84(3):241-6. PubMed ID: 1883598
[TBL] [Abstract][Full Text] [Related]
27. The effect of subtype-selective muscarinic receptor antagonists on the cholinergic current in motoneurons of the lobster cardiac ganglion.
Freschi JE
Brain Res; 1991 Jun; 552(1):87-92. PubMed ID: 1913185
[TBL] [Abstract][Full Text] [Related]
28. Effect of central muscarinic receptors on passive-avoidance learning deficits induced by prenatal pentylenetetrazol kindling in male offspring.
Pourmotabbed A; Mahmoodi G; Mahmoodi S; Mohammadi-Farani A; Nedaei SE; Pourmotabbed T; Pourmotabbed T
Neuroscience; 2014 Oct; 279():232-7. PubMed ID: 25168725
[TBL] [Abstract][Full Text] [Related]
29. Administration of muscarinic antagonists induce changes in passive avoidance learning and in synaptic transmission in the CA1 area of the hippocampus.
Dobryakova YV; Ivanova OY; Markevich VA
Acta Neurobiol Exp (Wars); 2018; 78(2):132-139. PubMed ID: 30019704
[TBL] [Abstract][Full Text] [Related]
30. The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory.
Dawson GR; Iversen SD
Behav Brain Res; 1993 Nov; 57(2):143-53. PubMed ID: 8117420
[TBL] [Abstract][Full Text] [Related]
31. A peptide muscarinic toxin from the Green Mamba venom shows agonist-like action in an inhibitory avoidance learning task.
Jerusalinsky D; Cerveñansky C; Walz R; Bianchin M; Izquierdo I
Eur J Pharmacol; 1993 Aug; 240(1):103-5. PubMed ID: 8405118
[TBL] [Abstract][Full Text] [Related]
32. Reversal caused by n-butylidenephthalide from the deficits of inhibitory avoidance performance in rats.
Hsieh MT; Wu CR; Lin LW; Hsieh CC; Tsai CH
Planta Med; 2001 Feb; 67(1):38-42. PubMed ID: 11270720
[TBL] [Abstract][Full Text] [Related]
33. Facilitation of memory storage by the acetylcholine M2 muscarinic receptor antagonist AF-DX 116.
Baratti CM; Opezzo JW; Kopf SR
Behav Neural Biol; 1993 Jul; 60(1):69-74. PubMed ID: 8216161
[TBL] [Abstract][Full Text] [Related]
34. Central pressor effects induced by muscarinic receptor agonists: evidence for a predominant role of the M2 receptor subtype.
Pazos A; Wiederhold KH; Palacios JM
Eur J Pharmacol; 1986 Jun; 125(1):63-70. PubMed ID: 3732392
[TBL] [Abstract][Full Text] [Related]
35. Involvement of dorsal hippocampal muscarinic cholinergic receptors on muscimol state-dependent memory of passive avoidance in mice.
Jafari-Sabet M
Life Sci; 2011 Jun; 88(25-26):1136-41. PubMed ID: 21557951
[TBL] [Abstract][Full Text] [Related]
36. Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats.
Roldán G; Bolaños-Badillo E; González-Sánchez H; Quirarte GL; Prado-Alcalá RA
Neurosci Lett; 1997 Jul; 230(2):93-6. PubMed ID: 9259472
[TBL] [Abstract][Full Text] [Related]
37. Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane .
Bymaster FP; Shannon HE; Rasmussen K; Delapp NW; Mitch CH; Ward JS; Calligaro DO; Ludvigsen TS; Sheardown MJ; Olesen PH; Swedberg MD; Sauerberg P; Fink-Jensen A
Eur J Pharmacol; 1998 Sep; 356(2-3):109-19. PubMed ID: 9774240
[TBL] [Abstract][Full Text] [Related]
38. M2 muscarinic receptors mediate pressor responses to cholinergic agonists in the ventrolateral medullary pressor area.
Sundaram K; Krieger AJ; Sapru H
Brain Res; 1988 May; 449(1-2):141-9. PubMed ID: 3293701
[TBL] [Abstract][Full Text] [Related]
39. Cholinergic stimulation of drinking from the lateral hypothalamus: indications for M2 muscarinic receptor mediation.
Hagan JJ; Tonnaer JA; Broekkamp CL
Pharmacol Biochem Behav; 1987 Apr; 26(4):771-9. PubMed ID: 3602034
[TBL] [Abstract][Full Text] [Related]
40. Facilitation of amphetamine-induced rotation by muscarinic antagonists is correlated with M2 receptor affinity.
Hagan JJ; Tonnaer JA; Rijk H; Broekkamp CL; van Delft AM
Brain Res; 1987 Apr; 410(1):69-73. PubMed ID: 3580900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
